800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis (IPF-COMFORT)

view all Clinical Trials

Overview

A two way, placebo controlled, cross-over study, to evaluate the effect of two doses of orvepitant on cough in patients with IPF.

Clinical Trial Information

Protocol

TIRB# 30521

Phase

2

Condition(s)

Interstitial Lung Disease (ILD), Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis (Including IPF)

Investigator

N/A

Coordinator

Kritti Mittal

Visit clinicaltrials.gov for full description.

Contact

For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.

Full Title

A Double-Blind, Randomised, Placebo Controlled, Two Period Cross-Over Study to Evaluate the Efficacy and Safety of Orvepitant in Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis